Skip to main navigation Skip to search Skip to main content

Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications

  • Sungjin Min
  • , Suran Kim
  • , Woo-Sup Sim
  • , Yi Sun Choi
  • , Hyebin Joo
  • , Jae-Hyun Park
  • , Su-Jin Lee
  • , Hyeok Kim
  • , Mi Jeong Lee
  • , Inhea Jeong
  • , Baofang Cui
  • , Sung-Hyun Jo
  • , Jin-Ju Kim
  • , Seok Beom Hong
  • , Yeon-Jik Choi
  • , Kiwon Ban
  • , Yun-Gon Kim
  • , Jang-Ung Park
  • , Hyang-Ae Lee
  • , Hun-Jun Park*
  • Seung-Woo Cho*
*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

41 Downloads (CityUHK Scholars)

Abstract

Engineered human cardiac tissues have been utilized for various biomedical applications, including drug testing, disease modeling, and regenerative medicine. However, the applications of cardiac tissues derived from human pluripotent stem cells are often limited due to their immaturity and lack of functionality. Therefore, in this study, we establish a perfusable culture system based on in vivo-like heart microenvironments to improve human cardiac tissue fabrication. The integrated culture platform of a microfluidic chip and a three-dimensional heart extracellular matrix enhances human cardiac tissue development and their structural and functional maturation. These tissues are comprised of cardiovascular lineage cells, including cardiomyocytes and cardiac fibroblasts derived from human induced pluripotent stem cells, as well as vascular endothelial cells. The resultant macroscale human cardiac tissues exhibit improved efficacy in drug testing (small molecules with various levels of arrhythmia risk), disease modeling (Long QT Syndrome and cardiac fibrosis), and regenerative therapy (myocardial infarction treatment). Therefore, our culture system can serve as a highly effective tissue-engineering platform to provide human cardiac tissues for versatile biomedical applications. © The Author(s) 2024.


Original languageEnglish
Article number2564
JournalNature Communications
Volume15
Online published22 Mar 2024
DOIs
Publication statusPublished - 2024

Funding

This work was supported by the National Research Foundation of Korea (NRF) grants (2021R1A2C3004262 to S.-W.C. and 2022R1A2C2009067 to H.-J.P.) funded by the Korea government, the Ministry of Science and ICT (MSIT). This work was supported by the Bio & Medical Technology Development Program (2022M3A9B6082675 to S.-W.C.) of the NRF funded by the MSIT and the Technology Innovation Program (20024298 to S.-W.C., Materials/Components Technology Development Program) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea). This work was also supported by the Institute for Basic Science (IBS-R026-D1) and the Yonsei Signature Research Cluster Program (2023-22-0012 to S.-W.C.). This work was supported by the Yonsei Fellow Program funded by Lee Youn Jae.

Research Keywords

  • Humans
  • Endothelial Cells
  • Induced Pluripotent Stem Cells
  • Cell Differentiation
  • Myocytes, Cardiac
  • Tissue Engineering/methods

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications'. Together they form a unique fingerprint.

Cite this